US filing analysis · 10-K
Sorted by SEC acceptance time (filing date when unavailable). Page 8 · 30 shown · up to 30 per page
DGX
Quest Diagnostics said net revenues for 2024 increased 6.7% compared to the prior year, and DIS revenues increased 7.1%. DIS volume increased 5.5% and revenue per requisition increased 1.3%, the company said, adding that recent acquisitions contributed approximately 3.9% to DIS revenues.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 20, 2025
Quest DiagnosticsDGX$258.28-0.31%
DDOG
Datadog said revenue for fiscal 2024 was $2,684.3 million, an increase of 26% from fiscal 2023 of $2,128.4 million, with approximately 75% of the $555.9 million increase attributable to growth from existing customers and 25% attributable to growth from new customers.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 20, 2025
DatadogDDOG$157.53-5.37%
CSGP
CoStar Group said 2024 revenues increased $281 million, or 11%, to $2.7 billion. The company cited increases in Multifamily revenues of $153 million, or 17%, CoStar revenues of $95 million, or 10%, and Residential revenues of $55 million, or 118%, as segment items.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
CoStar GroupCSGP$29.64+3.28%
CPT
Camden Property Trust said net income attributable to common shareholders was $163.3 million in 2024 and $403.3 million in 2023. The company cited as factors for the decrease a reduction in gain on sale from $225.4 million in 2023 to $43.8 million in 2024 and recognition of $41.0 million in impairment associated with land development activities in 2024.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
Camden Property TrustCPT$95.8-0.50%
COF
Capital One reported net income of $4.8 billion ($11.59 per diluted common share) and total net revenue of $39.1 billion for 2024. For 2023, the company reported net income of $4.9 billion ($11.95 per diluted common share) and total net revenue of $36.8 billion.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
Capital OneCOF$178.66-1.71%
BKNG
Booking Holdings said global room nights in 2024 increased 9% year-over-year. Total revenues increased approximately 11%, and on a constant-currency basis excluding the impact of foreign currency exchange rate changes, total revenues increased approximately 12% year-over-year.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
Booking HoldingsBKNG$144.93-1.62%
BG
Bunge Global said net income attributable to Bunge shareholders for 2024 was $1,137 million, a decrease of $1,106 million from $2,243 million in the prior year, and Total EBIT was $1,792 million, a decrease of $1,541 million.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 20, 2025
Bunge GlobalBG$90.9-0.93%
BALL
Ball Corporation said 2024 net sales decreased $267 million compared to 2023, and net earnings attributable to Ball Corporation increased $3.30 billion. The company cited discontinued operations, net of tax, of $3.36 billion as a factor in the net earnings increase.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
Ball CorporationBALL$63.490.00%
AMP
Ameriprise Financial said pretax income for 2024 increased $1.0 billion, or 32%, compared to the prior year. The company cited the cumulative impact of wrap net inflows and improved transactional activity, higher investment portfolio yields and other factors as drivers of the year-over-year change.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
Ameriprise FinancialAMP$480.29-2.45%
AME
AMETEK said 2024 net sales were $6,941.2 million, an increase of $344.2 million or 5.2%, and net income was $1,376.1 million, with diluted earnings per share of $5.93. The company said the net sales increase was due to a 7% increase from acquisitions, partially offset by a 2% organic sales decline.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 20, 2025
AMETEKAME$222.9-3.57%
ADM
Archer-Daniels-Midland said earnings before income taxes for 2024 decreased 47%, or $2.0 billion, to $2.3 billion. The company cited lower pricing and execution margins and an impairment charge of $461 million related to its investment in Wilmar as factors, with increased sales volumes partially offsetting these declines.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 20, 2025
Archer-Daniels-MidlandADM$66.95-0.27%
WM
On November 4, 2024, Waste Management completed its acquisition of all outstanding shares of Stericycle for $62.00 per share in cash. The total enterprise value of the acquisition was $7.2 billion (net of cash acquired). The post-closing operating results of Stericycle have been included in the Consolidated Financial Statements as a new reportable segment referred to as WM Healthcare Solutions.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
Waste ManagementWM$239.63+0.40%
TYL
Tyler Technologies said total revenues for the 12 months of 2024 increased 9.5% compared to the prior period, with revenues from recent acquisitions contributing $10.4 million or 0.5% to the total revenue increase. Subscriptions revenue grew 15.8%, which the company cited as primarily due to an ongoing shift toward SaaS arrangements for both new and existing clients.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
Tyler TechnologiesTYL$404.44+0.07%
TPL
Texas Pacific Land said total revenues for the year ended December 31, 2024 increased $705.8 million, or 11.8%, compared to $631.6 million in the prior year, and net income was $454.0 million, or 11.9% higher than 2023.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
Texas Pacific LandTPL$267.44-3.70%
PCAR
The company said worldwide net sales and revenues decreased to $33.66 billion in 2024 from $35.13 billion in 2023, and net income decreased to $4.16 billion ($7.90 per diluted share) in 2023 from $4.60 billion ($8.76 per diluted share).
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
PACCARPCAR$102.3-1.78%
LLY
Eli Lilly said revenue in 2024 increased driven by increased volume and, to a lesser extent, higher realized prices. The company cited Mounjaro, Zepbound, and Verzenio as drivers of the revenue increase, with Trulicity partially offsetting the growth.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
Eli LillyLLY$1,347.11-0.30%
GRMN
Garmin said net sales in fiscal 2024 increased 20%, and total unit sales rose approximately 15% to 16.2 million from 18.6 million. Outdoor represented the largest portion of the revenue mix at 31%.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
GarminGRMN$268.04-1.38%
GNRC
Generac said gross profit margin for the year ended December 31, 2024 was 38.8% compared to 33.9% in the prior year. Net income attributable to Generac Holdings Inc. was $316.3 million compared to $214.6 million in the prior year, and the company cited favorable sales mix, lower input costs, and plant efficiencies as drivers of the gross profit margin increase.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
GeneracGNRC$193.22-5.79%
CRL
Charles River Laboratories said fiscal 2024 revenue was $4.0 billion, a decrease of $79.4 million or 1.9% from fiscal 2023 revenue of $4.1 billion. Operating income was $227.3 million with an operating income margin of 5.6%, down from $617.3 million or 14.9% in fiscal 2023.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 19, 2025
Charles River LaboratoriesCRL$314.32-4.15%
AWK
For 2024, diluted earnings per share (GAAP) were $5.39, compared to $4.90 in 2023 and $4.51 in 2022. The company cited the implementation of new rates in the Regulated Businesses as the primary driver of results, and said the net impact of warmer, drier weather compared to normal in 2024 was $0.12 per share.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 19, 2025
American Water WorksAWK$149.53+0.84%
UDR
UDR said net income attributable to common stockholders for 2024 was $84.8 million ($0.26 per diluted share), down from $439.5 million ($1.34 per share) in the prior year. The company cited a smaller gain on the sale of real estate of $16.9 million compared to $351.2 million in the prior year among the factors.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 18, 2025
UDRUDR$35.45+0.34%
SWK
On April 1, 2024, Stanley Black & Decker sold its Infrastructure business to Epiroc AB for net proceeds of $728.5 million and used the net proceeds to reduce debt in Q2 2024.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 18, 2025
Stanley Black & DeckerSWK$106.62-0.95%
OXY
Occidental completed its $12.4 billion acquisition of CrownRock in 2024, issued $9.7 billion in new debt in July 2024 and assumed $1.2 billion of existing CrownRock debt in August. As of December 31, 2024, principal debt outstanding was $24.4 billion.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 18, 2025
Occidental PetroleumOXY$53.9+0.17%
MGM
MGM Resorts said consolidated net revenues for 2024 increased 7% compared to 2023, with MGM China and MGM Digital each increasing 28%. Consolidated operating income decreased 21%, which the company attributed to a $399 million gain on the sale of Gold Strike Tunica operations in the prior year and increases in payroll and other expenses.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 18, 2025
MGM ResortsMGM$32.36-3.14%
HOOD
Robinhood Markets said net income for 2024 was $1.41 billion, or diluted EPS of $1.56, compared to a net loss of $0.54 billion, or diluted EPS of -$0.61, in the prior year. Net income included a $369 million deferred tax benefit and a $55 million benefit from a reversal of an accrual as part of a regulatory settlement.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 18, 2025
Robinhood MarketsHOOD$62.94-8.32%
ETR
Entergy said its 2024 results included pension settlement charges of $320 million, costs related to the Entergy Louisiana agreement of $151 million, write-offs of an Entergy Arkansas regulatory asset of $132 million, and regulatory charges at Entergy New Orleans of $78 million.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 18, 2025
EntergyETR$104.38-1.70%
CNC
Centene said premium and service revenues for 2024 were $145.5 billion, representing 4% growth, diluted EPS was $6.31 compared to $4.95 for 2023, and adjusted diluted EPS was $7.17 compared to $6.68 for 2023.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 18, 2025
CenteneCNC$63.78-2.74%
CEG
Constellation Energy entered into an Agreement and Plan of Merger with Calpine Corporation on January 10, 2025 under which it will acquire all the outstanding equity interests of Calpine in a cash and stock transaction. Completion is conditioned upon review by the DOJ and approval by the FERC, NYPSC, PUCT and other regulatory bodies, as well as other customary closing conditions.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 18, 2025
Constellation EnergyCEG$237.56-5.74%
BSX
Boston Scientific said net sales for 2024 were $16.747 billion, an increase of $2.507 billion or 17.6% compared to 2023 net sales of $14.240 billion, with organic net sales growth of 16.4%.
US filing analysisUS10-K · Annual reportPublished Oct 11, 2026 (UTC)SEC filing date Feb 18, 2025
Boston ScientificBSX$41.98-2.35%
ALLE
Allegion said net revenues for 2024 increased by 3.3%, or $121.4 million, compared to the prior year. The company said improved pricing and the impact from acquisitions made during the year drove the increase, which was partially offset by lower volumes and unfavorable foreign currency exchange rate movements.
US filing analysisUS10-K · Annual reportPublished Oct 12, 2026 (UTC)SEC filing date Feb 18, 2025
AllegionALLE$183.61-1.27%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.